These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 3893271)
1. Clinical drug trials in Alzheimer's disease. Crook T Ann N Y Acad Sci; 1985; 444():428-36. PubMed ID: 3893271 [No Abstract] [Full Text] [Related]
2. [Pharmacological correction of Alzheimer's disease (review of the literature)]. Groppa SA Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):110-6. PubMed ID: 1686127 [No Abstract] [Full Text] [Related]
3. Therapeutic progress--review XVIII Alzheimer's disease. Kendall MJ; Chellingsworth MC; Main AN J Clin Hosp Pharm; 1985 Dec; 10(4):327-36. PubMed ID: 2869054 [No Abstract] [Full Text] [Related]
4. Pharmacology of dementia. Klawans HL; Genovese N Neurol Clin; 1986 May; 4(2):459-67. PubMed ID: 2872586 [TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy of memory loss in the geriatric patient. Galizia VJ Drug Intell Clin Pharm; 1984 Oct; 18(10):784-91. PubMed ID: 6149111 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Alzheimer's disease: hopes and reality. Gauthier S; Gauthier L; Bouchard R; Quirion R; Sultan S Can J Neurol Sci; 1991 Aug; 18(3 Suppl):439-41. PubMed ID: 1933695 [TBL] [Abstract][Full Text] [Related]
7. [Remarks on the drug treatment of demented patients]. Wettstein A Schweiz Arch Neurol Psychiatr (1985); 1985; 136(4):101-6. PubMed ID: 2413531 [TBL] [Abstract][Full Text] [Related]
8. Cholinergic approaches to the treatment of Alzheimer's disease. Hollander E; Mohs RC; Davis KL Br Med Bull; 1986 Jan; 42(1):97-100. PubMed ID: 3006861 [No Abstract] [Full Text] [Related]
9. Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit. Byrne EJ; Arie T BMJ; 1990 Apr; 300(6732):1132-3; discussion 1131. PubMed ID: 2160850 [No Abstract] [Full Text] [Related]
10. Combination therapy with galantamine and memantine improves behavioral and psychological symptoms of dementia (BPSD) in patients with early-onset Alzheimer's disease. Hamuro A Aust N Z J Psychiatry; 2013 Jun; 47(6):583. PubMed ID: 23093052 [No Abstract] [Full Text] [Related]
11. No response to high-dose muscarinic agonist therapy in Alzheimer's disease. Mouradian MM; Mohr E; Williams JA; Chase TN Neurology; 1988 Apr; 38(4):606-8. PubMed ID: 3281057 [TBL] [Abstract][Full Text] [Related]
12. [Cholinergic treatment strategies in Alzheimer's disease]. Kurz A; Rüster P; Romero B; Zimmer R Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472 [No Abstract] [Full Text] [Related]
13. Intracranial drug administration in Alzheimer's disease. Harbaugh RE Psychopharmacol Bull; 1986; 22(1):106-9. PubMed ID: 3726055 [No Abstract] [Full Text] [Related]
14. [Cholinergic agents in the treatment of Alzheimer's disease]. Zemishlany Z; Davidson M; Davis KL Harefuah; 1987 Dec; 113(12):401-4. PubMed ID: 3330722 [No Abstract] [Full Text] [Related]
15. Effects of cholinergic enhancement therapies on memory function in Alzheimer's disease: a meta-analysis of the literature. Jorm AF Aust N Z J Psychiatry; 1986 Jun; 20(2):237-40. PubMed ID: 3464268 [TBL] [Abstract][Full Text] [Related]
16. Cholinergic drugs in Alzheimer's disease. Davis KL; Mohs RC N Engl J Med; 1986 Nov; 315(20):1286-7. PubMed ID: 3773941 [No Abstract] [Full Text] [Related]
17. [The effects of cholinergic preparations in Alzheimer's disease]. Bradley RJ; Edge MT; Freeman AM Farmakol Toksikol; 1991; 54(3):4-10. PubMed ID: 1915820 [No Abstract] [Full Text] [Related]